Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A near-infrared fluorescence imaging marker, also known as a near-infrared fluorophore or dye, is not a single molecule or biological target, but rather refers to any chemical compound that absorbs light in the near-infrared spectrum (~700–1400 nm) and emits detectable fluorescent signals at longer wavelengths. These markers are widely used in biomedical research and clinical practice because they enable non-invasive visualization of tissues, organs, blood vessels, lymphatics, tumors—and even plant structures—deep within living organisms due to reduced autofluorescence from tissues at these wavelengths.[3][4][5] Commonly used examples include indocyanine green (ICG), heptamethine dyes like IR808/IRDye800CW conjugates with targeting antibodies such as bevacizumab–800CW.[6] They do not interact with endogenous cellular targets like receptors or enzymes unless specifically conjugated to targeting ligands/antibodies designed for molecular recognition.[2] Their primary role is as contrast agents that enhance intraoperative navigation during cancer surgeries,[6] monitor tissue perfusion,[3] visualize sentinel lymph nodes,[5] detect pathological angiogenesis,[1], among other applications. Because this term does not specify any particular protein/gene/receptor/enzyme, it should be considered incorrect if entered into structured databases intended only for true biological targets.
Not applicable in the context of drug targeting; mechanism relates to their function as contrast agents: Absorb near-infrared light and emit fluorescence at longer wavelengths. Enable real-time visualization when excited by appropriate light sources during medical procedures[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Near-infrared fluorescence imaging marker.